Max Donley
2021 - Aurinia Pharmaceuticals
In 2021, Max Donley earned a total compensation of $730.2K as EVP, Operations and Strategy at Aurinia Pharmaceuticals, a 78% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $269,392 |
|---|---|
| Salary | $448,986 |
| Other | $11,828 |
| Total | $730,206 |
Donley received $449K in salary, accounting for 61% of the total pay in 2021.
Donley also received $269.4K in non-equity incentive plan and $11.8K in other compensation.
Rankings
In 2021, Max Donley's compensation ranked 9,763rd out of 12,412 executives tracked by ExecPay. In other words, Donley earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,763 out of 12,412 | 21st |
Division Manufacturing | 4,323 out of 5,498 | 21st |
Major group Chemicals And Allied Products | 1,921 out of 2,374 | 19th |
Industry group Drugs | 1,705 out of 2,095 | 19th |
Industry Pharmaceutical Preparations | 1,266 out of 1,542 | 18th |
Pay ratio
| Max Donley's Pay | $730,206 |
|---|---|
| Median Employee's Pay | $255,489 |
| Pay Ratio | 3to 1 |
In 2021, the annual total compensation of Max Donley was $730,206.
The annual total compensation of the median employee at Aurinia Pharmaceuticals was $255,489.
The ratio of Max Donley's pay to the pay of median employee was therefore 3 to one.
Source: SEC filing on April 18, 2022.
Donley's colleagues
We found four more compensation records of executives who worked with Max Donley at Aurinia Pharmaceuticals in 2021.